Composition and method for treatment of glaucoma
Patent 4476140 Issued on October 9, 1984. Estimated Expiration Date: 
May 16, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 16, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3631039 Pharmacologically effective substance from plants belonging to the family of Labiatae Polyoxygenated labdane derivatives Patent #: 4134986 InventorsApplicationNo. 06/494652 filed on 05/16/1983US Classes:514/455, Chalcogen bonded directly to ring carbon of the hetero ring514/913GlaucomaExaminersPrimary: Robinson, Douglas W.Attorney, Agent or FirmInternational ClassA61K 31/35 (20060101)AbstractTopical administration of one of the polyoxygenated Labdanes of which forskolin is an example to the eyes produces lower intraocular pressure. The topical application to the eye produces no significant changes in blood pressure or pulse rate. The polyoxygenated Labdanes are effective agents for the treatment of glaucoma. | |
